Substitution of N-4 piperazine of CP with 4-chlorophenylcarbamoyl led to a new CP derivative with potent anti-proliferative activity against non-small cell lung cancer (Figure 1).36 The gene discussed is CP; the disease is non-small cell lung carcinoma.